Opinion Article - International Journal of Clinical Rheumatology (2024) Volume 19, Issue 12
Osteonecrosis: Understanding the Disease and Current Approaches to Management
Sarah Tansley Tansley*
Department of Public Health and Pharmacology, and Medical Education, University of Porto, Portugal
- *Corresponding Author:
- Sarah Tansley Tansley
Department of Public Health and Pharmacology, and Medical Education, University of Porto, Portugal
E-mail: tansley.s@nhs.net
Received: 02-Dec-2024, Manuscript No. fmijcr-25-159735; Editor assigned: 04- Dec-2024, Pre-QC No. fmijcr-25-159735 (PQ); Reviewed: 18-Dec-2024, QC No. fmijcr-25-159735; Revised: 23-Dec-2024, Manuscript No. fmijcr-25-159735 (R); Published: 30-Dec-2024, DOI: 10.37532/1758- 4272.2024.19(12).374-376
Abstract
Osteonecrosis (ON), also referred to as avascular necrosis, is a disorder where the bone tissue dies due to a lack of blood flow. While the hip is most commonly affected, osteonecrosis can involve any bone and is associated with various risk factors such as trauma, corticosteroid use, alcohol abuse, and certain systemic diseases like lupus and sickle cell anemia. The condition can lead to chronic pain, functional limitations, and, if left untreated, joint collapse. Timely diagnosis and intervention are crucial in preventing severe damage and preserving joint function. This review comprehensively examines osteonecrosis, covering its pathophysiological mechanisms, risk factors, diagnostic challenges, and current management strategies, including both medical and surgical treatment options. It also explores promising new treatments, such as stem cell therapies and advanced surgical techniques, which hold potential for improving patient outcomes.
Keywords
Arthritis • Bone • Necrosis
Introduction
Osteonecrosis, often referred to as avascular necrosis or ischemic bone necrosis, is a debilitating condition characterized by the death of bone tissue due to a lack of blood supply. This condition primarily affects weightbearing joints such as the hip and knee, but it can also occur in other bones throughout the body. In this review article, we will delve into the key aspects of osteonecrosis, including its causes, risk factors, clinical presentation, diagnostic methods, and treatment options [1].
Osteonecrosis, a condition also known as avascular necrosis or ischemic bone necrosis, is a complex and debilitating disorder characterized by the progressive death of bone tissue due to an insufficient blood supply. This condition poses a significant challenge to patients and healthcare providers alike, as it often results in pain, joint dysfunction, and reduced quality of life. While osteonecrosis can affect various bones in the body, it predominantly targets weight-bearing joints, such as the hip and knee. The underlying causes of osteonecrosis can be diverse, ranging from traumatic injuries and the use of certain medications to underlying medical conditions and lifestyle factors. The pathophysiology of osteonecrosis revolves around the disruption of blood flow to the affected bone, ultimately leading to tissue death and structural damage [2]. Early diagnosis and intervention are crucial in managing osteonecrosis effectively. This review article aims to provide a comprehensive overview of the condition, encompassing its causes, risk factors, clinical presentation, diagnostic methods, and treatment options. By exploring these facets, we aim to shed light on the complexities of osteonecrosis and the diverse approaches available to mitigate its impact on patients' lives [3].
Causes and risk factors
Osteonecrosis can be idiopathic, meaning its cause is unknown, or it can be attributed to several factors. The most common cause is the disruption of the blood supply to the bone. This disruption can result from trauma, corticosteroid use, alcohol abuse, or certain medical conditions such as sickle cell disease. Other risk factors include excessive alcohol consumption, smoking, and the use of specific medications, particularly highdose corticosteroids. The clinical presentation of osteonecrosis can vary depending on the affected joint and the stage of the disease. Initially, patients may experience joint pain, which is often insidious and worsens over time. As the condition progresses, limited joint range of motion, stiffness, and muscle weakness may develop. In advanced stages, joint collapse and deformities can occur, leading to severe disability [4, 5].
Diagnostic methods
Early diagnosis of osteonecrosis is crucial to prevent further joint damage. Imaging studies such as X-rays, magnetic resonance imaging (MRI), and bone scans are commonly used to detect changes in the affected bone. MRI is particularly effective in the early stages, as it can reveal areas of decreased blood flow and bone damage. Blood tests may also be performed to rule out underlying conditions and assess the overall health of the patient [6-8].
Staging and classification
Osteonecrosis is often classified into different stages to guide treatment decisions. The most widely used classification system is the Ficat and Arlet system, which categorizes osteonecrosis into four stages:
- Stage 0: No radiographic abnormalities.
- Stage I: Normal X-ray, but MRI may show early changes.
- Stage II: X-ray shows evidence of bone damage.
- Stage III: Structural collapse of the affected bone.
- Stage IV: Severe joint damage.
Treatment options
The choice of treatment for osteonecrosis depends on the stage of the disease, the affected joint, and the patient's overall health. Conservative management includes pain relief with nonsteroidal anti-inflammatory drugs (NSAIDs) or analgesics, physical therapy to improve joint function, and lifestyle modifications such as weight loss and limiting alcohol intake. For patients with advanced disease or joint collapse, surgical interventions may be necessary. Core decompression, where a hole is drilled into the affected bone to relieve pressure and stimulate blood flow, is a common procedure. Jointpreserving surgeries like osteotomy (bone reshaping) and vascularized bone grafting can also be considered. In severe cases where joint destruction is irreversible, joint replacement surgery (arthroplasty) may be the best option to restore function and relieve pain [9, 10].
Conclusion
Osteonecrosis is a challenging and potentially debilitating condition that can significantly impact a patient's quality of life. Early diagnosis and appropriate management are essential to prevent joint damage and preserve joint function. Understanding the causes, risk factors, clinical presentation, diagnostic methods, and treatment options discussed in this review can aid healthcare providers in effectively managing this condition and improving patient outcomes. Further research is needed to develop more advanced treatment strategies for osteonecrosis and to better understand its underlying mechanisms.
References
- Chen SB, Hu H, Gao YS et al. Prevalence of clinical anxiety, clinical depression and associated risk factors in Chinese young and middle-aged patients with osteonecrosis of the femoral head. PLoS ONE. 10,e0120234(2015).
- Shimizu J, Okazaki S, Nagoya S et al. Susceptibility of males, but not females to developing femoral head osteonecrosis in response to alcohol consumption. PLoS ONE. 11, 0165490(2016).
- Cui L, Zhuang Q, Lin J et al. Multicentric epidemiologic study on six thousand three hundred and ninety five cases of femoral head osteonecrosis in China. Int Orthop. 40, 267-276(2016)
- Ghaleb RM, Omar GM, Ibrahim MA. Avascular necrosis of bone in systemic lupus erythematosus. Egypt Rheumatol. 33(1), 27-33(2011).
- Gheita TA, Azkalany GS, Kenawy SA et al. Bone scintigraphy in axial seronegative spondyloarthritis patients: role in detection of subclinical peripheral arthritis and disease activity. Int J Rheum Dis. 18 (5), 553-559 (2015).
- Ouédraogo DD, Nacoulma EWC, Kafando E et al. Rheumatologic diseases and haemoglobinopathies in Ouagadougou. Bull Soc Pathol Exot. 103, 80-83(2010).
- Oniankitan O, Kakpovi K, Fianyo E et al. Risk factors of hip osteoarthritis in Lomé, Togo. Med Trop. 69, 59-60(2009).
- Onyemaechi NO, Enweani UN, Maduka CO. Musculoskeletal complications of sickle cell disease in Enugu, Nigeria. Niger J Med. 20, 456-461(2011).
- Arlet J, Ficat P. Non-traumatic avascular femur head necrosis. New methods of examination and new concepts. Chir Narzadow Ruchu Ortop Pol. 42, 269-76(1977).
- Ikeuchi K, Hasegawa Y, Seki T. Epidemiology of nontraumatic osteonecrosis of the femoral head in Japan. Mod Rheumatol. 25, 278-328(2015).
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref